Aspartic acid hexapeptide

Aspartic acid hexapeptide has been studied in 1 paper since 2022: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Dec 20, 2022: “An Acid-Sensitive Bone Targeting Delivery System Carrying Acacetin Prevents Osteoporosis in Ovariectomized Mice”.

1 paper studies itUpdated Dec 20, 2022

See all 1 papers on aspartic acid hexapeptide

Animals1

Latest

PharmaceuticalsDec 20

An Acid-Sensitive Bone Targeting Delivery System Carrying Acacetin Prevents Osteoporosis in Ovariectomized Mice

Experiments in micePostmenopausal osteoporosis